TY - JOUR
T1 - Gonadotropin-Releasing Hormone Agonist Versus Recombinant Human Chorionic Gonadotropin Triggering in Fertility Preservation Cycles
AU - Herzberger, Einat Haikin
AU - Knaneh, Sabaa
AU - Amir, Hadar
AU - Reches, Adi
AU - Ben-Yosef, Dalit
AU - Kalma, Yael
AU - Azem, Foad
AU - Samara, Nivin
N1 - Publisher Copyright:
© 2021, Society for Reproductive Investigation.
PY - 2021/12
Y1 - 2021/12
N2 - The purpose of this research is to study the efficacy of GnRH-a versus r-hCG triggering in patients who go through fertility preservation cycles. This retrospective cohort study was performed in a tertiary university–affiliated medical center. It includes 191 patients undergoing fertility preservation cycles between May 2013 and September 2018, in which ovulation was induced by either GnRH-a or r-hCG. Main outcome measures were number and rate of mature oocyte. Among treatment cycles with medical indication, GnRH agonist significantly increases the odds for high mature rate by 3.55 (1.30–9.66), while in treatment cycles with social indication, there is no significant effect of the triggering agent. An advantage for GnRH-a triggering was observed in medically indicated preservation cycles.
AB - The purpose of this research is to study the efficacy of GnRH-a versus r-hCG triggering in patients who go through fertility preservation cycles. This retrospective cohort study was performed in a tertiary university–affiliated medical center. It includes 191 patients undergoing fertility preservation cycles between May 2013 and September 2018, in which ovulation was induced by either GnRH-a or r-hCG. Main outcome measures were number and rate of mature oocyte. Among treatment cycles with medical indication, GnRH agonist significantly increases the odds for high mature rate by 3.55 (1.30–9.66), while in treatment cycles with social indication, there is no significant effect of the triggering agent. An advantage for GnRH-a triggering was observed in medically indicated preservation cycles.
KW - Cancer patients
KW - Elective fertility preservation
KW - Onco-fertility preservation
KW - Oocyte cryopreservation
KW - Ovarian stimulation
UR - http://www.scopus.com/inward/record.url?scp=85107201911&partnerID=8YFLogxK
U2 - 10.1007/s43032-021-00622-2
DO - 10.1007/s43032-021-00622-2
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34076872
AN - SCOPUS:85107201911
SN - 1933-7191
VL - 28
SP - 3390
EP - 3396
JO - Reproductive Sciences
JF - Reproductive Sciences
IS - 12
ER -
